Teva Announces FDA Approval of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. SPY
5. ACN
6. IBM
7. META
8. PFE
9. TSLA
10. DPZ

Go back to Teva Announces FDA Approval of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 32.99 +0.79 (2.45%)
Previous Close $32.20    52 Week High $66.55 
Open $32.14    52 Week Low $37.82 
Day High $33.26    P/E N/A 
Day Low $32.12    EPS $0.00 
Volume 2,017,937       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 32.99 +0.79 (2.45%)
Previous Close $32.20    52 Week High $66.55 
Open $32.14    52 Week Low $37.82 
Day High $33.26    P/E N/A 
Day Low $32.12    EPS $0.00 
Volume 2,017,937